H19 dysregulation has also been implicated in a variety of other cancers such as colorectal cancer (Tsang et al., 2010), hepatocellular carcinoma (HCC; Ariel et al., 1998), breast cancer (Lottin et al., 2002), and bladder cancer (Luo et al., 2013), among others. The gene discussed is H19; the disease is breast carcinoma.